This page has only limited features, please log in for full access.
Diabetes mellitus (DM) represents an independent risk factor for chronic AF and is associated with unfavorable outcomes. We aimed to evaluate the efficacy and safety of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF), with and without diabetes mellitus (DM), using a new risk index (RI) defined as: RI
Domenico Acanfora; Marco Ciccone; Valentina Carlomagno; Pietro Scicchitano; Chiara Acanfora; Alessandro Bortone; Massimo Uguccioni; Gerardo Casucci. A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index. Journal of Clinical Medicine 2021, 10, 2924 .
AMA StyleDomenico Acanfora, Marco Ciccone, Valentina Carlomagno, Pietro Scicchitano, Chiara Acanfora, Alessandro Bortone, Massimo Uguccioni, Gerardo Casucci. A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index. Journal of Clinical Medicine. 2021; 10 (13):2924.
Chicago/Turabian StyleDomenico Acanfora; Marco Ciccone; Valentina Carlomagno; Pietro Scicchitano; Chiara Acanfora; Alessandro Bortone; Massimo Uguccioni; Gerardo Casucci. 2021. "A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index." Journal of Clinical Medicine 10, no. 13: 2924.
In recent weeks, adverse reactions have been reported after administration of Oxford–AstraZeneca chimpanzee adenovirus vectored vaccine ChAdOx1 nCoV-19 (AZD1222), in particular thrombus formation, which has led several European Countries to discontinue administration of this vaccine. On March 8, 2021, the European Medicines Agency Safety Committee did not confirm this probable association. We report the case of a patient who developed disseminated intravascular coagulation after the first dose of Oxford-Astra Zeneca vaccine, which resolved in a few days with the administration of dexamethasone and enoxaparin. This work demonstrates the safety of the Oxford-Astra Zeneca vaccine and that any development of side effects can be easily managed with a prompt diagnosis and in a short time with a few commonly used drugs.
Gerardo Casucci; Domenico Acanfora. DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination. Viruses 2021, 13, 1046 .
AMA StyleGerardo Casucci, Domenico Acanfora. DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination. Viruses. 2021; 13 (6):1046.
Chicago/Turabian StyleGerardo Casucci; Domenico Acanfora. 2021. "DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination." Viruses 13, no. 6: 1046.